{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:58:40Z","timestamp":1793480320927,"version":"4.5.0"},"reference-count":22,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2016,4,13]],"date-time":"2016-04-13T00:00:00Z","timestamp":1460505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Academic Emergency Medicine"],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Acetaminophen (<jats:styled-content style=\"fixed-case\">APAP<\/jats:styled-content>) is a mainstay for pain management worldwide. The intravenous (<jats:styled-content style=\"fixed-case\">IV<\/jats:styled-content>) formulation has been widely used in Europe for more than 20 years in adults and children. In the United States, <jats:styled-content style=\"fixed-case\">IV APAP<\/jats:styled-content> obtained full approval from the Food and Drug Administration in 2010. There is emerging literature to suggest the use of <jats:styled-content style=\"fixed-case\">IV APAP<\/jats:styled-content> for pain reduction in the emergency department (<jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>). This evidence\u2010based review examines the evidence pertaining to the use of <jats:styled-content style=\"fixed-case\">IV APAP<\/jats:styled-content> for acute pain control in the <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The <jats:styled-content style=\"fixed-case\">MEDLINE<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">EMBASE<\/jats:styled-content> databases were searched. Randomized controlled trials (<jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content>s) that described or evaluated the use of <jats:styled-content style=\"fixed-case\">IV APAP<\/jats:styled-content> for acute pain in the <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content> were included. Duplicate articles, unpublished reports, abstracts, review articles, and non\u2010English literature were excluded. The\u00a0primary outcome of interest in this review was the difference in pain score between <jats:styled-content style=\"fixed-case\">IV APAP<\/jats:styled-content> and active comparator or placebo from baseline to a cutoff time specified in the original trials. Secondary outcome measures were the incidence of adverse events and reduction in the amount of adjuvant analgesics consumed by patients who received <jats:styled-content style=\"fixed-case\">IV APAP<\/jats:styled-content>. Methodologic quality of the trials was assessed using the Grading of Recommendations Assessment, Development, and Evaluation criteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fourteen <jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content>s with various methodologic flaws, which enrolled a total of 1,472 patients, met the inclusion criteria. The level of evidence for the individual trials ranged from very low to moderate. In three of the 14 trials, a significant reduction in pain scores was observed in patients who received <jats:styled-content style=\"fixed-case\">IV APAP<\/jats:styled-content>. The first trial found a significant reduction in mean pain scores when <jats:styled-content style=\"fixed-case\">IV APAP<\/jats:styled-content> was compared to <jats:styled-content style=\"fixed-case\">IV<\/jats:styled-content> morphine at 30\u00a0minutes after drug administration (4.7\u00a0\u00b1\u00a02.3 vs. 2.9\u00a0\u00b1\u00a02.2). In the second trial, patients who received <jats:styled-content style=\"fixed-case\">IV APAP<\/jats:styled-content> reported of lower pain scores (31.7\u00a0\u00b1\u00a018 mm, 95% confidence interval [<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>]\u00a0= 8.2 to 25.2 mm) compared to those who received <jats:styled-content style=\"fixed-case\">IV<\/jats:styled-content> morphine (48.3\u00a0\u00b1\u00a014.1 mm, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\u00a0= 8.2 to 25.2 mm), 15\u00a0minutes after drug administration. A third trial found a significant reduction (p\u00a0=\u00a00.005) in the mean pain scores when <jats:styled-content style=\"fixed-case\">IV APAP<\/jats:styled-content> was compared to intramuscular piroxicam at 90\u00a0minutes after drug administration. In the remaining eight trials, pain scores were not statistically different when <jats:styled-content style=\"fixed-case\">IV APAP<\/jats:styled-content> was compared to other pain medications. The incidence of side effects associated with <jats:styled-content style=\"fixed-case\">IV APAP<\/jats:styled-content> was very low.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Fourteen <jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content>s with various methodologic flaws provided limited evidence to support the use of <jats:styled-content style=\"fixed-case\">IV APAP<\/jats:styled-content> as the primary analgesic for acute pain control in patients who present to the <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/acem.12921","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T17:08:55Z","timestamp":1454087335000},"page":"543-553","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The Use of Intravenous Acetaminophen for Acute Pain in the Emergency Department"],"prefix":"10.1111","volume":"23","author":[{"given":"Billy","family":"Sin","sequence":"first","affiliation":[{"name":"The Arnold &amp; Marie Schwartz College of Pharmacy Long Island University Brooklyn NY"},{"name":"The Department of Pharmacy Division of Pharmacotherapy Services Emergency Department Clinical Research Program Department of Emergency Medicine The Brooklyn Hospital Center Brooklyn NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Wai","sequence":"additional","affiliation":[{"name":"Yale New Haven Hospital New Haven CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Tatunchak","sequence":"additional","affiliation":[{"name":"The Department of Pharmacy Division of Pharmacotherapy Services Emergency Department Clinical Research Program Department of Emergency Medicine The Brooklyn Hospital Center Brooklyn NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey M.","family":"Motov","sequence":"additional","affiliation":[{"name":"The Department of Emergency Medicine Maimonides Medical Center Brooklyn NY"},{"name":"The SUNY Downstate Medical Center Brooklyn NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,4,13]]},"reference":[{"key":"e_1_2_9_2_1","first-page":"53","article-title":"Intravenous acetaminophen and intravenous ketorolac for management of pediatric surgical pain: a literature review","volume":"82","author":"Baley K","year":"2014","journal-title":"AANA J"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1511"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.2344\/0003-3006-61.3.99"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2011.01141.x"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.2011.01085.x"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2010.00426.x"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.06.005"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/571326"},{"key":"e_1_2_9_11_1","first-page":"e14903","article-title":"Comparison of paracetamol (Apotel\u00ae) and morphine in reducing post pure head trauma headache","volume":"21","author":"Shams Vahdati S","year":"2014","journal-title":"Anesth Pain Med"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2011-200165"},{"key":"e_1_2_9_13_1","first-page":"1983","article-title":"Tramadol or paracetamol do not effect the diagnostic accuracy of acute abdominal pain with significant pain relief \u2010 a prospective, randomized, placebo controlled double blind study","volume":"16","author":"Oguzturk J","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2013-203044"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2009.09.019"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00590-013-1392-x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2012-201670"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2009.06.501"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2010.104687"},{"key":"e_1_2_9_20_1","first-page":"66","article-title":"The comparison of Apotel plus low dose morphine and full dose of morphine in pain relief in patients with acute renal colic","volume":"7","author":"Morteza\u2010Bagi HR","year":"2015","journal-title":"Addict Health"},{"key":"e_1_2_9_21_1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.36076\/ppj.2015\/18\/249","article-title":"A new transmucous\u2010buccal formulation of acetaminophen for acute traumatic pain: a non\u2010inferiority, randomized, double\u2010blind, clinical trial","volume":"18","author":"Pickering G","year":"2015","journal-title":"Pain Physician"},{"key":"e_1_2_9_22_1","first-page":"772","article-title":"Comparing the analgesic effect of intravenous acetaminophen and morphine on patients with renal colic pain referring to the emergency department: a randomized controlled trial","volume":"18","author":"Azizkhani R","year":"2013","journal-title":"J Res Med Sci"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/0960327114551394"}],"container-title":["Academic Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Facem.12921","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/acem.12921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T10:30:34Z","timestamp":1695724234000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/acem.12921"}},"subtitle":[],"editor":[{"given":"Shahriar","family":"Zehtabchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,13]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1111\/acem.12921"],"URL":"https:\/\/doi.org\/10.1111\/acem.12921","archive":["Portico"],"relation":{},"ISSN":["1069-6563","1553-2712"],"issn-type":[{"value":"1069-6563","type":"print"},{"value":"1553-2712","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,13]]},"assertion":[{"value":"2015-10-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-12-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}